Dynamic local unfolding in the serpin α-1 antitrypsin provides a mechanism for loop insertion and polymerization

Nature Structural and Molecular Biology

Volumn 18, Issue 2, 2011, Pages 222-227

  Krishnan, Beena ^a   Gierasch, Lila M ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CYSTEINE; SERINE PROTEINASE INHIBITOR;

ARTICLE; ENERGY; ENZYME DEFECT; MOLECULAR EVOLUTION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; SERPINOPATHY;

ALPHA 1-ANTITRYPSIN; CYSTEINE; HUMANS; MODELS, MOLECULAR; MUTATION; POLYMERIZATION; PROTEIN CONFORMATION; PROTEIN UNFOLDING;

EID: 79551646854     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.1976     Document Type: Article

References (37)

1. Gettins, P.G. Serpin structure, mechanism, and function. Chem. Rev. 102, 4751-4804 (2002).
2. Huntington, J.A., Read, R.J. & Carrell, R.W. Structure of a serpin-protease complex shows inhibition by deformation. Nature 407, 923-926 (2000).
3. Dupont, D.M. et al. Biochemical properties of plasminogen activator inhibitor-1. Front. Biosci. 14, 1337-1361 (2009).
4. Mushunje, A., Evans, G., Brennan, S.O., Carrell, R.W. & Zhou, A. Latent antithrombin and its detection, formation and turnover in the circulation. J. Thromb. Haemost. 2, 2170-2177 (2004).
5. Kaslik, G. et al. Effects of serpin binding on the target proteinase: global stabilization, localized increased structural fexibility, and conserved hydrogen bonding at the active site. Biochemistry 36, 5455-5464 (1997).
6. Wang, Z., Mottonen, J. & Goldsmith, E.J. Kinetically controlled folding of the serpin plasminogen activator inhibitor 1. Biochemistry 35, 16443-16448 (1996).
7. Gooptu, B. & Lomas, D.A. Conformational pathology of the serpins: themes, variations, and therapeutic strategies. Annu. Rev. Biochem. 78, 147-176 (2009).
8. Tran, S.T. & Shrake, A. The folding of α-1-proteinase inhibitor: kinetic vs equilibrium control. Arch. Biochem. Biophys. 385, 322-331 (2001).
9. Yamasaki, M., Li, W., Johnson, D.J. & Huntington, J.A. Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature 455, 1255-1258 (2008).
10. Yamasaki, M., Sendall, T.J., Harris, L.E., Lewis, G.M. & Huntington, J.A. The loop-sheet mechanism of serpin polymerization tested by reactive center loop mutations. J. Biol. Chem. 285, 30752-30758 (2010).
11. Ekeowa, U.I. et al. Defning the mechanism of polymerization in the serpinopathies. Proc. Natl. Acad. Sci. USA 107, 17146-17151 (2010).
12. James, E.L., Whisstock, J.C., Gore, M.G. & Bottomley, S.P. Probing the unfolding pathway of α1-antitrypsin. J. Biol. Chem. 274, 9482-9488 (1999).
13. Cabrita, L.D., Whisstock, J.C. & Bottomley, S.P. Probing the role of the F-helix in serpin stability through a single tryptophan substitution. Biochemistry 41, 4575-4581 (2002).
14. Whisstock, J.C. & Bottomley, S.P. Serpins' mystery solved. Nature 455, 1189-1190 (2008).
15. Tsutsui, Y. & Wintrode, P.L. Cooperative unfolding of a metastable serpin to a molten globule suggests a link between functional and folding energy landscapes. J. Mol. Biol. 371, 245-255 (2007).
16. Seo, E.J., Im, H., Maeng, J.S., Kim, K.E. & Yu, M.H. Distribution of the native strain in human α 1-antitrypsin and its association with protease inhibitor function. J. Biol. Chem. 275, 16904-16909 (2000).
17. Lu, J. & Deutsch, C. PEGylation: a method for assessing topological accessibilities in Kv1.3. Biochemistry 40, 13288-13301 (2001).
18. Bottomley, S.P., Hopkins, P.C. & Whisstock, J.C. Alpha 1-antitrypsin polymerisation can occur by both loop A and C sheet mechanisms. Biochem. Biophys. Res. Commun. 251, 1-5 (1998).
19. Tew, D.J. & Bottomley, S.P. Probing the equilibrium denaturation of the serpin α (1)-antitrypsin with single tryptophan mutants; evidence for structure in the urea unfolded state. J. Mol. Biol. 313, 1161-1169 (2001).
20. Powell, L.M. & Pain, R.H. Effects of glycosylation on the folding and stability of human, recombinant and cleaved α 1-antitrypsin. J. Mol. Biol. 224, 241-252 (1992).
21. Knaupp, A.S., Levina, V., Robertson, A.L., Pearce, M.C. & Bottomley, S.P. Kinetic instability of the serpin Z α1-antitrypsin promotes aggregation. J. Mol. Biol. 396, 375-383 (2010).
22. Brantly, M., Courtney, M. & Crystal, R.G. Repair of the secretion defect in the Z form of α 1-antitrypsin by addition of a second mutation. Science 242, 1700-1702 (1988).
23. Zhou, A., Stein, P.E., Huntington, J.A. & Carrell, R.W. Serpin polymerization is prevented by a hydrogen bond network that is centered on His-334 and stabilized by glycerol. J. Biol. Chem. 278, 15116-15122 (2003).
24. Kim, J., Lee, K.N., Yi, G.S. & Yu, M.H. A thermostable mutation located at the hydrophobic core of α 1-antitrypsin suppresses the folding defect of the Z-type variant. J. Biol. Chem. 270, 8597-8601 (1995).
25. Zaimidou, S. et al. A1ATVar: a relational database of human SERPINA1 gene variants leading to α1-antitrypsin defciency and application of the VariVis software. Hum. Mutat. 30, 308-313 (2009).
26. Levina, V. et al. Expression, purifcation and characterization of recombinant Z α (1)-antitrypsin-the most common cause of α (1)-antitrypsin defciency. Protein Expr. Purif. 68, 226-232 (2009).
27. Clark, P. & Chong, A.Y. Rare α 1 antitrypsin allele PI W and a history of infant liver disease. Am. J. Med. Genet. 45, 674-676 (1993).
28. Yu, M.H., Lee, K.N. & Kim, J. The Z type variation of human α 1-antitrypsin causes a protein folding defect. Nat. Struct. Biol. 2, 363-367 (1995).
29. Lomas, D.A. New insights into the structural basis of α 1-antitrypsin defciency. Q. J. Med. 89, 807-812 (1996).
30. Mahadeva, R. et al. Polymers of Z α1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am. J. Pathol. 166, 377-386 (2005).
31. Elliott, P.R., Pei, X.Y., Dafforn, T.R. & Lomas, D.A. Topography of a 2.0 Å structure of α1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci. 9, 1274-1281 (2000).
32. Laska, M.E. The effect of dissolved oxygen on recombinant protein degradation in Escherichia coli. PhD thesis. (Massachusetts Institute of Technology, Cambridge, Massachusetts, USA, 2001).
33. Ignatova, Z. & Gierasch, L.M. Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant. Proc. Natl. Acad. Sci. USA 103, 13357-13361 (2006).
34. Nath, U. & Udgaonkar, J.B. Perturbation of a tertiary hydrogen bond in barstar by mutagenesis of the sole His residue to Gln leads to accumulation of at least one equilibrium folding intermediate. Biochemistry 34, 1702-1713 (1995).
35. Weissman, J.S. & Kim, P.S. Reexamination of the folding of BPTI: predominance of native intermediates. Science 253, 1386-1393 (1991).
36. Hansen, R.E. & Winther, J.R. An introduction to methods for analyzing thiols and disulfdes: Reactions, reagents, and practical considerations. Anal. Biochem. 394, 147-158 (2009).
37. Salsbury, F.R. Jr, Knutson, S.T., Poole, L.B. & Fetrow, J.S. Functional site profling and electrostatic analysis of cysteines modifable to cysteine sulfenic acid. Protein Sci. 17, 299-312 (2008).